Insiders Eiger BioPharmaceuticals, Inc.

Equities

EIGR

US28249U2042

Delayed OTC Markets Other stock markets 12:33:27 2024-05-09 EDT			5-day change	1st Jan Change
2.25 ^USD	-13.46%		-6.25%	-66.59%

05-08	Sentynl Therapeutics, Inc. acquired Global rights to Zokinvy Eiger BioPharmaceuticals, Inc. (OTCPK:EIGR.Q) for $45.2 million.	CI
05-06	Zydus Lifesciences Arm Acquires Eiger BioPharmaceuticals' Progeria Drug	MT

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Eiger BioPharmaceuticals, Inc. Announces Resignation of Jeffrey S. Glenn as Member of the Board of Directors	04-03	CI
Eiger BioPharmaceuticals, Inc. Announces Christine A. Murray Notifies Resignation as Member of Board of Directors, Effective March 15, 2024	03-11	CI
Ldon Mayer Iii Notifies Eiger BioPharmaceuticals, Inc. of His Resignation as the Chief Commercial Officer, Effective February 2, 2024	01-24	CI
Eiger BioPharmaceuticals Names David Apelian Permanent Chief Executive; Cuts Workforce by 25%	23-06-29	MT
Eiger Biopharmaceuticals, Inc. Appoints David Apelian, as CEO	23-06-29	CI
Eiger BioPharmaceuticals, Inc. Appoints William G. Kachioff as Chief Financial Officer	23-04-14	CI
Eiger BioPharmaceuticals Names William Kachioff CFO, James Vollins General Counsel	23-04-13	MT
Codexis Appoints Chief Financial Officer	23-01-23	MT
Eiger BioPharmaceuticals, Inc. Announces Sriram Ryali to Resign as Chief Financial Officer, Effective January 20, 2023	23-01-09	CI
Insider Buy: Eiger Biopharmaceuticals	22-12-27	MT
Eiger BioPharmaceuticals Chief Executive David Cory Resigns; Interim CEO Named	22-12-16	MT
Eiger BioPharmaceuticals, Inc. Announces CEO Changes	22-12-15	CI
Eiger BioPharmaceuticals Announces Management Changes	22-12-15	CI
Eiger BioPharmaceuticals, Inc. Appoints Lisa Kelly-Croswell to Board of Directors	22-07-18	CI
Eiger Biopharmaceuticals, Inc. Announces New Executive Appointments	22-04-18	CI
Eiger BioPharmaceuticals, Inc. Appoints Erik Atkisson as General Counsel and Chief Compliance Officer	21-09-21	CI
Eiger BioPharmaceuticals, Inc. Appoints Kim Sablich to its Board of Directors	21-04-22	CI
Eiger Biopharmaceuticals, Inc. Announces Resignation of Stephana Patton as Corporate Secretary and General Counsel	21-04-09	CI
Eiger Biopharmaceuticals, Inc. Announces Executive Changes	20-01-07	CI
Eiger Biopharmaceuticals, Inc. Names Mark Mannebach as Vice President of Global Regulatory Affairs	19-06-10	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Eiger BioPharmaceuticals, Inc.

Equities

EIGR

US28249U2042

Insiders

Filters